QOL Performance Chemicals
We offer products that contribute to better quality of life, supporting people and their everyday living and helping to realize a comfortable society.
*Horizontally scrollable
| Area | Area of contribution | Category | Main corresponding product groups |
|---|---|---|---|
| QOL Performance Chemicals |
Contribution to healthcare | Medical treatment | Wound treatment materials (medical devices), hemostatic agents (medical devices), potting resins for artificial kidneys |
| Screenings | Clinical test reagents (in vitro diagnostic reagents) | ||
| Medicines, etc. | Enteric coating agents (pharmaceutical additives), active ingredients for bowel cleansing formulations (pharmaceuticals) |
||
| Infection | Antibacterial agents (pharmaceuticals) | ||
| R&D | Functional proteins and extracellular (Japanese only), vesicle purification kits (Biomedical, Japanese only) | ||
| Contribution to solving food security | Stable supply | Peptides for Agriculture (Japanese only), land-based aquaculture peptides | |
| Contribution to a comfortable life | Improvement of safety | Flame retardants, antistatic agents (Japanese only) | |
| Improvement of convenience | Electronic noses (Japanese only), ingredients for household detergents | ||
| Improvement of quality | Memory foam, ingredients for cosmetics (Japanese only) |
Overview of QOL Performance Chemicals
In our New Medium-Term Management Plan 2025, we have positioned products that contribute to carbon neutrality and improved quality of life as high value-added products, and are planning aggressive capital investment for FY2021-FY2025. QOL Performance Chemicals support one of three areas of contribution—“healthcare,” “food security,” and “a comfortable life”—and targets have been set for each product.
Sales composition ratio
Capital Investment in QOL Performance Chemicals
A New Growth Path: Creating Next-Generation Businesses
Our New Medium-Term Management Plan 2025 focuses on creating next-generation businesses that will lead to a new growth path toward 2030, with the aim of quickly commercializing them.
Functional Protein, Silk-Elastin
Silk-Elastin, a regenerative medical material that creates an environment for repair and regeneration of biological tissue
Silk-Elastin is a functional protein created using gene recombination technology. Featuring a high affinity with human cells, it creates an environment for cell proliferation that promotes the repair and regeneration of biological tissues. In treating chronic wounds (like diabetic foot ulcers) and acute wounds (like burns), medical professionals have seen good results even in cases where standard treatments were unlikely to work. Clinical trial findings on meniscus regeneration and wound treatment were also published in Scientific Reports. We obtained regulatory approval for Silk-Elastin as a new wound treatment material in May 2025 and plan to commence sales by the end of FY2025.
Expected market and future potential
The global market for Silk-Elastin for meniscus regeneration applications is expected to be worth over 100 billion yen, with the U.S. accounting for more than half of this total. We plan to first establish a track record in wound treatment applications, and then develop Silk-Elastin into a pillar of our business by 2030 for meniscus regeneration applications, for which there is a large market.
Electronic Nose, FlavoTone
FlavoTone, Type-A
FlavoTone, Type-G
In November 2023, we launched FlavoTone an electric nose that can visualize complex and diverse odors using a mechanism similar to human olfaction. Since it can visualize both specific odors and complex odors, it offers solutions such as odor-based quality control, characteristic comparison, and monitoring. It is also equipped with an application that uses machine learning to analyze the obtained data, enabling output tailored to needs and applications, such as quality control, characteristic comparison, and monitoring. The FlavoTone Business Promotion Dept. has received inquiries about joint research from various parties, and we aim to achieve an operating profit of 1 billion yen by 2030.
Peptide Agriculture
We are involved in R&D on agricultural peptides* that allow plants to express properties they naturally lack, and that can bring out various plant functions more easily and safely than with conventional breeding. By improving plant resistance to stress caused by climate change and other factors, the yield and quality of agricultural crops are expected to improve. We will actively establish new peptide agriculture and provide agricultural support.
- Peptides play a key role in plant metabolism and information transmission between tissues, and are essential components for adapting to the growing environment and improving resistance.
